OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and safety of azilsartan medoxomil, an angiotensin receptor blocker, in Korean patients with essential hypertension
Attila Juhász, Jingtao Wu, Michie Hisada, et al.
Clinical Hypertension (2018) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Attila Juhász, Jingtao Wu, Michie Hisada, et al.
Clinical Hypertension (2018) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Showing 5 citing articles:
A phase 3 double-blind randomized (CONSORT-compliant) study of azilsartan medoxomil compared to valsartan in Chinese patients with essential hypertension
Jiahui Wu, Xin Du, Qiang Lv, et al.
Medicine (2020) Vol. 99, Iss. 32, pp. e21465-e21465
Open Access | Times Cited: 8
Jiahui Wu, Xin Du, Qiang Lv, et al.
Medicine (2020) Vol. 99, Iss. 32, pp. e21465-e21465
Open Access | Times Cited: 8
Efficacy and safety of different doses of azilsartan medoxomil in patients with hypertension
Yan Zhang, Hui‐Jin Yu, Kangmei Shao, et al.
Medicine (2019) Vol. 98, Iss. 36, pp. e17050-e17050
Open Access | Times Cited: 3
Yan Zhang, Hui‐Jin Yu, Kangmei Shao, et al.
Medicine (2019) Vol. 98, Iss. 36, pp. e17050-e17050
Open Access | Times Cited: 3
Efficacy and safety of azilsartan medoxomil in the treatment of hypertension: a systematic review and meta-analysis
Ling Zhu, Guocui Wei, Qing Xiao, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access
Ling Zhu, Guocui Wei, Qing Xiao, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access
A Prospective Study of Azilsartan Medoxomil in the Treatment of Patients with Essential Hypertension and Type 2 Diabetes in Asia
Chaicharn Deerochanawong, Kuan‐Cheng Chang, Yu Cho Woo, et al.
International Journal of Hypertension (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 2
Chaicharn Deerochanawong, Kuan‐Cheng Chang, Yu Cho Woo, et al.
International Journal of Hypertension (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 2
Developing a multi-center clinical data mart of ACEI and ARB for real-world evidence (RWE)
Hun‐Sung Kim, Sue Hyun Lee, T Kim, et al.
Clinical Hypertension (2018) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Hun‐Sung Kim, Sue Hyun Lee, T Kim, et al.
Clinical Hypertension (2018) Vol. 24, Iss. 1
Open Access | Times Cited: 1
